MAIA BIOTECHNOLOGY INC (MAIA) Fundamental Analysis & Valuation

NYSEARCA:MAIA • US5526411021

Current stock price

1.33 USD
-0.01 (-0.75%)
At close:
1.34 USD
+0.01 (+0.75%)
After Hours:

This MAIA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MAIA Profitability Analysis

1.1 Basic Checks

  • MAIA had negative earnings in the past year.
  • In the past year MAIA has reported a negative cash flow from operations.
  • MAIA had negative earnings in each of the past 5 years.
  • In the past 5 years MAIA always reported negative operating cash flow.
MAIA Yearly Net Income VS EBIT VS OCF VS FCFMAIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • MAIA's Return On Assets of -189.61% is on the low side compared to the rest of the industry. MAIA is outperformed by 87.04% of its industry peers.
  • MAIA's Return On Equity of -53571.70% is on the low side compared to the rest of the industry. MAIA is outperformed by 83.17% of its industry peers.
Industry RankSector Rank
ROA -189.61%
ROE -53571.7%
ROIC N/A
ROA(3y)-208.41%
ROA(5y)-324.93%
ROE(3y)-1657.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAIA Yearly ROA, ROE, ROICMAIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

1.3 Margins

  • MAIA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAIA Yearly Profit, Operating, Gross MarginsMAIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MAIA Health Analysis

2.1 Basic Checks

  • MAIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MAIA Yearly Shares OutstandingMAIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MAIA Yearly Total Debt VS Total AssetsMAIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • MAIA has an Altman-Z score of -15.42. This is a bad value and indicates that MAIA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -15.42, MAIA is doing worse than 81.24% of the companies in the same industry.
  • There is no outstanding debt for MAIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.42
ROIC/WACCN/A
WACCN/A
MAIA Yearly LT Debt VS Equity VS FCFMAIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

  • MAIA has a Current Ratio of 1.18. This is a normal value and indicates that MAIA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.18, MAIA is not doing good in the industry: 84.53% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.18 indicates that MAIA should not have too much problems paying its short term obligations.
  • The Quick ratio of MAIA (1.18) is worse than 84.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
MAIA Yearly Current Assets VS Current LiabilitesMAIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MAIA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.78% over the past year.
EPS 1Y (TTM)35.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, MAIA will show a very strong growth in Earnings Per Share. The EPS will grow by 200.07% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.54%
EPS Next 2Y276.97%
EPS Next 3Y200.07%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAIA Yearly Revenue VS EstimatesMAIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 100M 200M 300M 400M
MAIA Yearly EPS VS EstimatesMAIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. MAIA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MAIA. In the last year negative earnings were reported.
  • Also next year MAIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAIA Price Earnings VS Forward Price EarningsMAIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAIA Per share dataMAIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MAIA's earnings are expected to grow with 200.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y276.97%
EPS Next 3Y200.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MAIA Dividend Analysis

5.1 Amount

  • MAIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MAIA Fundamentals: All Metrics, Ratios and Statistics

MAIA BIOTECHNOLOGY INC

NYSEARCA:MAIA (4/2/2026, 8:04:00 PM)

After market: 1.34 +0.01 (+0.75%)

1.33

-0.01 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-23
Earnings (Next)05-07
Inst Owners6.8%
Inst Owner Change10.63%
Ins Owners12.93%
Ins Owner Change7.77%
Market Cap78.02M
Revenue(TTM)N/A
Net Income(TTM)-22.34M
Analysts82.86
Price Target12.38 (830.83%)
Short Float %3.54%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.42%
Min EPS beat(2)-39.32%
Max EPS beat(2)26.47%
EPS beat(4)3
Avg EPS beat(4)16.6%
Min EPS beat(4)-39.32%
Max EPS beat(4)66.39%
EPS beat(8)5
Avg EPS beat(8)16.05%
EPS beat(12)8
Avg EPS beat(12)12.64%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.16%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1875.43
P/tB 1875.43
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -189.61%
ROE -53571.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-208.41%
ROA(5y)-324.93%
ROE(3y)-1657.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -15.42
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-0.54%
EPS Next 2Y276.97%
EPS Next 3Y200.07%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.05%
EBIT Next 3YN/A
EBIT Next 5Y38.76%
FCF growth 1Y-35.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.76%
OCF growth 3YN/A
OCF growth 5YN/A

MAIA BIOTECHNOLOGY INC / MAIA Fundamental Analysis FAQ

What is the fundamental rating for MAIA stock?

ChartMill assigns a fundamental rating of 2 / 10 to MAIA.


What is the valuation status for MAIA stock?

ChartMill assigns a valuation rating of 1 / 10 to MAIA BIOTECHNOLOGY INC (MAIA). This can be considered as Overvalued.


How profitable is MAIA BIOTECHNOLOGY INC (MAIA) stock?

MAIA BIOTECHNOLOGY INC (MAIA) has a profitability rating of 0 / 10.